HCID 13677845, 화합물 → HCID 76610493, 화합물

HRID 1948369노트

반응식

HRID 1948369 반응식
[N:1]([CH:4]1[CH2:9][CH2:8][N:7]([C:10]([O:12][CH2:13][CH3:14])=[O:11])[CH2:6][CH:5]1[OH:15])=[N+:2]=[N-:3].BrC1CCN(C(OCC)=O)CC1O[Si:29]([C:32]([CH3:35])([CH3:34])[CH3:33])([CH3:31])[CH3:30]>>[N:1]([CH:4]1[CH2:9][CH2:8][N:7]([C:10]([O:12][CH2:13][CH3:14])=[O:11])[CH2:6][CH:5]1[O:15][Si:29]([C:32]([CH3:35])([CH3:34])[CH3:33])([CH3:31])[CH3:30])=[N+:2]=[N-:3]

참가 물질

3

반응물 2

HCID 13677845HCID 13677845, 화합물HCID 68519870HCID 68519870, 화합물2회

생성물 1

HCID 76610493HCID 76610493, 화합물

실험 절차

The title compound was prepared in a manner analogous to (Intermediate 238) starting with ethyl 4-bromo-3-{[tert-butyl(dimethyl)silyl]oxy}piperidine-1-carboxylate (Intermediate 241). MS (GC-EI)[(M-N2)+]: 300 for C14H28N4O3Si.

출처 및 근거

ORD 기록
ord-ff02a4f1dcaf4cad9577dd4e48649d60
출처 데이터셋
uspto-grants-2013_03
특허 번호
US08399489B2

반응 노트

불러오는 중…